 |
|
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):230-241. Published online 2023 Jan 30 DOI: https://doi.org/10.3350/cmh.2022.0421
|
|
Citations to this article as recorded by
 Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
Feng‐Pai Tsai, Tung‐Hung Su, Shang‐Chin Huang, Tai‐Chung Tseng, Shih‐Jer Hsu, Sih‐Han Liao, Chun‐Ming Hong, Chen‐Hua Liu, Hung‐Chih Yang, Chun‐Jen Liu, Pei‐Jer Chen, Jia‐Horng Kao
Cancer.2025;[Epub] CrossRef Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Sih-Han Liao, Shih-Jer Hsu, Chun-Ming Hong, Ting-Yuan Lan, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Jia-Horng Kao
American Journal of Gastroenterology.2025; 120(2): 401. CrossRef Editorial: PIVKA‐II Facilitates Risk Stratification for HCC Following HCV Cure
Tung‐Hung Su, Wei‐Chih Liao
Alimentary Pharmacology & Therapeutics.2025; 61(3): 583. CrossRef Precision surgery for hepatocellular carcinoma
Christian Tibor Josef Magyar, Luckshi Rajendran, Zhihao Li, Vanessa Banz, Arndt Vogel, Grainne Mary O'Kane, Albert Chi-Yan Chan, Gonzalo Sapisochin
The Lancet Gastroenterology & Hepatology.2025;[Epub] CrossRef Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Yuliang Wang, Ayman El Baz, Ahmed A. Khalil, Naglaa Elarabany
Egyptian Liver Journal.2024;[Epub] CrossRef Role of reimbursement and Physicians' awareness in the survival of sorafenib‐eligible advanced hepatocellular carcinoma patients
Hui‐Ling Huang, Te‐Sheng Chang, Lariza Marie Canseco, Fan Wu, Sheng‐Nan Lu
The Kaohsiung Journal of Medical Sciences.2024; 40(6): 589. CrossRef Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma
Yiliang Wang, Nu Li, Letian Qu, Mu Zhang, Zhuo Li, Xiang Li, Dasheng Cai
Journal of Nanobiotechnology.2024;[Epub] CrossRef Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors
Dao-Han Zhang, Chen Liang, Shu-Yang Hu, Xiao-Yong Huang, Lei Yu, Xian-Long Meng, Xiao-Jun Guo, Hai-Ying Zeng, Zhen Chen, Lv Zhang, Yan-Zi Pei, Mu Ye, Jia-Bin Cai, Pei-Xin Huang, Ying-Hong Shi, Ai-Wu Ke, Yi Chen, Yuan Ji, Yujiang Geno Shi, Jian Zhou, Jia F
Journal of Translational Medicine.2024;[Epub] CrossRef Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression
Lakshmi Thangavelu, Abdulmalik S.A. Altamimi, Nehmat Ghaboura, M. Arockia Babu, R. Roopashree, Pawan Sharma, Pusparghya Pal, Chhavi Choudhary, G.V. Siva Prasad, Aashna Sinha, Ashok Kumar Balaraman, Sushama Rawat
Pathology - Research and Practice.2024; 263: 155652. CrossRef Expression and diagnostic value of abnormal prothrombin and osteopontin in hepatocellular carcinoma with cirrhosis
Guanjun Li
American Journal of Translational Research.2024; 16(9): 4688. CrossRef Calpain 2 promotes Lenvatinib resistance and cancer stem cell traits via both proteolysis-dependent and independent approach in hepatocellular carcinoma
Xiaolu Ma, Kaixia Zhou, Tianqing Yan, Ling Hu, Suhong Xie, Hui Zheng, Ying Tong, Heng Zhang, Yanchun Wang, Zhiyun Gong, Cuncun Chen, Yanan Tian, Lin Guo, Renquan Lu
Molecular Biomedicine.2024;[Epub] CrossRef Efficacy of transcatheter arterial chemoembolization combined with radiotherapy for locally advanced hepatocellular carcinoma
Lihua Liao
American Journal of Translational Research.2024; 16(11): 6935. CrossRef Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
Clinical and Molecular Hepatology.2023; 29(2): 349. CrossRef Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(2): 252. CrossRef Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
San-Chi Chen
Clinical and Molecular Hepatology.2023; 29(2): 352. CrossRef Viral Status and Treatment Efficacy in Recurrent Hepatocellular Carcinoma After Primary Resection
Hou-Ying Cheng, Rey-Heng Hu, Chih-Yang Hsiao, Ming-Chih Ho, Yao-Ming Wu, Po-Huang Lee, Cheng-Maw Ho
Journal of Gastrointestinal Surgery.2023; 27(8): 1594. CrossRef A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)
Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, Xiang-Shuo Kong
Frontiers in Pharmacology.2023;[Epub] CrossRef Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
Shamar Young, Jack Hannallah, Dan Goldberg, Tina Sanghvi, Junaid Arshad, Aaron Scott, Gregory Woodhead
International Journal of Molecular Sciences.2023; 24(14): 11434. CrossRef Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
Sang Hyun Seo, Kyung Joo Cho, Hye Jung Park, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Hee Cheon, Jong In Yook, Man-Deuk Kim, Dong Jin Joo, Seung Up Kim
Cell Communication and Signaling.2023;[Epub] CrossRef
|